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ABSTRACT
Background: Insufficient iron for erythropoiesis can occur in multiple conditions,
including absolute iron deficiency, which is often caused by chronic external
hemorrhage in dogs. Distinguishing this from other causes of iron-restricted
erythropoiesis allows appropriate intervention. Decreased marrow iron assessed
by Prussian blue staining is considered the gold standard to diagnose absolute
iron deficiency but scoring systems are not validated in dogs. The performance
of standardized semiquantitative marrow scoring of iron deposits in dogs has not
been previously reported or correlated to iron biomarkers in blood.[1-4]
Objectives: Objectives included evaluation of the effects of different staining
sequences, evaluation the technical performance of bone marrow scoring
systems used in human medicine, and assessment of the clinical utility of marrow
iron scoring (Gale method) and reticulocyte hemoglobin content (CHr) in healthy
and clinically ill canines with and without evidence of blood loss.
Results: Established human scoring via the Gale iron bone marrow classification
method (scale 0-6) can be applied to healthy and ill canine bone marrow
aspirates stained with Prussian blue with acceptable intraobserver (substantial to
perfect) and interobserver agreement (fair).[5] The Gale score did not correlate
with the CHr [reticulocyte hemoglobin content] as expected, given that CHr can
be affected by different types of iron restricted erythropoiesis. The odds of a low
CHr (equal or less than 24.4 pg) in a canine patient is approximately 3 times
higher in patients that have a low median Gale score (2 or less). Descriptive
statistics for Gale marrow scoring in clinically healthy research canines were as
follows: range (4-5), mean (4.3), and median (4.17). Most dogs with a low Gale
score and low CHr (equal or less than 24.4 pg) had absolute iron deficiency;
however, a few dogs had evidence of additional iron sequestration and functional
iron deficiency. A low Gale score and normal CHr could indicate a subclinical
iron deficiency.
Conclusions: The Gale scoring method performs well on canine bone marrow
aspirates but should always be interpreted together with CHr and other
laboratory data and clinical findings for accurate evaluation for one or more
potential processes of iron restricted-erythropoiesis in the patient.
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PREFACE
Bone marrow iron grading is important to identify absolute iron deficiency, which
in dogs is commonly due to chronic external blood loss, and to distinguish it from
other causes of iron deficiency. Veterinary medicine does not have a
standardized semi-quantitative method of grading iron stores during microscopic
evaluation of bone marrow samples. Marrow iron is often only reported as
present or absent. Establishing a grading system for iron scoring in dog marrow
and evaluating its clinical utility will help with diagnosis and treatment of absolute
iron deficiency.
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CHAPTER ONE
INTRODUCTION AND GENERAL INFORMATION
Background
Microscopic evaluation for decreased marrow iron stores has been considered
the practical gold standard for diagnosis of absolute iron deficiency, compared to
blood biomarkers of iron such as reticulocyte hemoglobin content (CHr), soluble
transferrin receptor, serum iron, total iron binding capacity (TIBC), and ferritin.[68] Veterinary pathologists commonly only classify marrow iron as present or
absent. However, human medicine utilizes two different iron marrow scoring
systems: the Gale method and sideroblast method.[6, 9] Respectively, these
reflect the total stored iron in the marrow and cellular utilization of iron.[6, 9]
These scoring systems require Prussian blue staining to highlight extracellular
and intracellular iron deposits.[7, 10] Prior to this study, there have not been any
published studies in canine marrow samples documenting differences in staining
sequences and the technical performance of these human iron grading
systems.[5] Further investigation of marrow iron along with blood biomarkers of
iron may give additional information about the type(s) of iron deficiency
processes in the canine patient and determine if the less invasive blood
biomarkers are acceptable alternatives to marrow sampling.
Because bone marrow sampling is an invasive and painful procedure, less
invasive blood biomarkers have been investigated as an alternative to aid in
determination of marrow iron status.[1-3, 11, 12] CHr has previously been
evaluated as a promising, non-invasive reflection of iron status in canines. [1, 4,
14-17] However, it is not a consistent indicator of absolute iron deficiency in
canines and does not discriminate between iron restricted erythropoiesis
categories (see below). [16] CHr is a measurement of the amount of hemoglobin
in reticulocytes and can be decreased in conditions of iron deficiency since iron is
an essential component of hemoglobin. Reticulocytes are newly formed red cells
that have been recently released from the bone marrow; therefore, CHr is a more
direct reflection of the patient’s current red cell hemoglobin content and iron
status when compared to the hemoglobin content of older red cells.[1, 4, 6] CHr
can have high sensitivity and specificity for diagnosis of absolute iron deficiency
in certain situations in humans.[13, 14] However, in both humans and canines,
CHr can be affected by iron sequestration (inflammation) and functional iron
deficiency.[4, 11] Evaluating Gale iron marrow scores concurrently with CHr may
elucidate how effectively CHr can be used as a surrogate marker of marrow iron
stores.
There are three broad categories of iron deficiency described below, and
distinction of these categories can be difficult, especially if only blood biomarkers
are available.[1-3, 11, 12] This study investigates utility of concurrent
1

semiquantitative iron marrow scoring, along with CHr and other blood iron
biomarkers, for classification of iron deficiency categories in the canine patient.

Categories of Iron Restricted Erythropoiesis
Iron restricted erythropoiesis is a condition in which there is inadequate iron
available for erythropoiesis to proceed normally. The three categories of iron
restricted erythropoiesis are absolute iron deficiency, iron sequestration, and
functional iron deficiency.[11] In dogs, absolute iron deficiency most commonly
occurs due to chronic blood loss, but may also occur with feeding of imbalanced
homemade or vegetarian diets.[11]
Iron sequestration applies to anemia of inflammation and chronic disease.[11, 14]
It occurs due to inflammatory cytokines (e.g. IL 6) driving an increase in hepcidin,
which is a main regulator of iron in the body.[11, 14, 15] Hepcidin causes the
degradation of portal exits (ferroportin) for intracellular iron. Without ferroportin,
iron is sequestered within cellular storage sites, such as intestinal epithelial cells,
macrophages, and hepatocytes, resulting in an iron deficient state and
consequential anemia.[14]
Functional iron deficiency occurs when there are adequate iron stores but
inadequate delivery of iron to erythroid precursors.[4, 7] It is seen when
erythropoietin (erythrocyte growth factor) is increased, promoting usage of iron
for erythropoiesis at an increased rate so that iron demand for erythropoiesis
exceeds supply via mobilization from tissue stores. This can be seen in patients
treated with exogenous erythropoietin or in patients with hemolytic anemia [3]

Diagnosis of Iron Deficiency Anemia
Diagnosis of the different types of iron restricted erythropoiesis is dependent
upon a holistic approach including history, clinical presentation, blood
biomarkers, and iron marrow stores. Documentation of chronic blood loss, diet,
inflammatory conditions, and administration of any type of erythropoietic
stimulant must be reported. Clinical presentation of symptomatic anemia such as
pallor, weakness, heart murmur, and possible melena must be noted.[16] Serum
iron and CHr are usually decreased in canines with anemia of inflammation or
absolute iron deficiency. Serum TIBC (an indicator of concentrations of serum
transferrin, the main serum iron transport protein) is not usually increased in
absolute iron deficiency or anemia of inflammation, and may be normal or
decreased.[17] Stainable marrow iron and serum ferritin (storage iron in blood)
are decreased in absolute iron deficiency, but both are adequate to increased in
anemia of inflammation. Patients with functional iron deficiency will have
adequate iron marrow stores but decreased iron available to erythroid
precursors.[4, 7] Semiquantification of marrow iron may be especially helpful
along with the blood biomarkers to determine the type of iron deficiency for
appropriate patient treatment.
2

Utility of Destaining Marrow Aspirates
Many veterinary clinical pathology laboratories stain routine bone marrow
aspirates with a Romanowsky stain such as Wright or Giemsa. These stains
highlight cellular detail to allow for evaluation of cell morphology, but iron is not
highlighted and can be difficult to see, especially in thickly prepared smears.
Additionally, in some cases only a small amount of marrow is collected, which
may yield only one or two diagnostic smears in which Romanowsky staining is
often prioritized based on the patient’s clinical needs. To avoid having to
resample the marrow in those cases, it would be useful to be able to destain
Romanowsky-stained smears after evaluation of cell morphology, then restain
the smears with Prussian blue if semi-quantification of iron is needed.

Evaluation of Iron Marrow
Qualitative assessment of marrow iron stores is a routine component of
microscopic marrow evaluation in dogs, where marrow iron stores are often
simply reported as present or absent. To date there are no published guidelines
for interpretation of semiquantitative iron assessments such as the Gale scoring
method in veterinary medicine. Therefore, it is unclear whether anemic dogs with
very small amounts of microscopically detectable iron should be diagnosed with
absolute iron deficiency or should be evaluated for other causes of anemia.
Microscopic marrow iron assessment does have notable limitations, though,
including that some studies in humans had significant interobserver variation in
assessment of iron stores. [6-8] To date there have been no publications to
evaluate the technical performance of the Gale or sideroblast iron grading
schemes in canine marrow samples. Additionally, there have been no studies to
evaluate the effect of destaining slide previously stained with a Romanowsky
stain before restaining with Prussian blue.
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CHAPTER TWO
LITERATURE REVIEW
Iron Marrow Scoring in Human Literature
Marrow iron scoring in humans is based on two scoring systems. The Gale
scoring system is semiquantitative and based on identification of large deposits
of storage iron within macrophages. The sideroblast scoring system is based on
identification of small iron granules in the cytoplasm of erythroid precursors.
Prussian blue staining is required for optimal visualization of iron by either
scoring system.
Gale Scoring
A semiquantitative scheme for assessing bone marrow iron stores, the Gale
method, has been described for humans.[18] It grades large deposits of
hemosiderin in macrophages of Prussian blue stained bone marrow smears on a
scale of 0 to 6, with grades of 1-3 considered normal (Table 1). [18, 19] Scores
are expected to be decreased with absolute iron deficiency, but may be
normal or increased in other causes of iron-restricted erythropoiesis.[7]
Sideroblast Scoring
A second method, the sideroblast method, has also been described in humans.
This method involves quantification of the percentage of nucleated red cell
precursors containing 1-5 fine cytoplasmic iron granules (“sideroblasts”), with
greater than 20-30% of erythroid precursors expected to be sideroblasts in
humans (Figure 1). [7] [9] Sideroblastic iron is theorized to provide a better
indication of cellular utilization of iron, and together with the Gale iron score might
aid in diagnosis of iron sequestration and functional iron deficiency. Both of
these conditions are associated with adequate iron scores (normal Gale score)
but insufficient iron availability to meet the increased demand.[7]

Challenges of Diagnosing Absolute Iron Deficiency
Several challenges may arise when diagnosing absolute iron deficiency based
solely on routine erythrocyte values from the Complete Blood Count (CBC) and
on iron biomarkers in blood.[2, 7, 20] Patients with iron sequestration and those
with absolute iron deficiency can both have a low CHr and low serum iron.[2, 3,
20] Additionally, a microcytic erythrocyte population (indicated by decreased
Mean Cell Volume [MCV] on the CBC and decreased CHr), is usually suggestive
of absolute iron deficiency, but can also be noted in patients with portosystemic
shunting and hereditary microcytosis (i.e. Akitas, Jindos, Shiba Inus, and Chow
breed canines).[2, 20] Using erythrocytes values and iron biomarkers are a less
4

invasive way to estimate marrow iron stores. However, a bone marrow aspirate
stained with Prussian blue is often required for definitive diagnosis of absolute
iron deficiency.[7]

Correlation of Biomarkers and Marrow Iron in Humans and
Canines
Many human studies have reported the correlation between blood iron
biomarkers and marrow iron stores. These blood biomarkers include but are not
limited to CHr, serum ferritin, MCV, Mean Cell Hemoglobin Concentration
(MCHC), low density hemoglobin, and TIBC.[7, 13, 15] Findings are similar in
canines and humans with absolute iron deficiency and include microcytosis
(decreased MCV), hypochromasia (decreased MCHC), low ferritin, and low CHr.
One notable difference is that TIBC is increased in humans in response to iron
deficiency anemia, whereas it is not commonly increased in canines.[17, 20]
One human study demonstrated that CHr had the highest sensitivity and
specificity for iron deficiency when compared to other iron biomarkers.[13]
Additionally some human studies incorporate C-reactive protein (CRP)
concentrations (increased in iron sequestration) and soluble transferrin receptor
concentrations (increased in absolute iron deficiency) as part of an intensive
marrow grading method.[7] This intensive method considerably improves the
ability to distinguish causes of iron restricted erythropoiesis in humans.[7]
However, the clinical utility of CRP in distinguishing causes of iron restriction in
dogs has not been thoroughly evaluated [4], and an assay for soluble transferrin
receptor is not available for canines.

Core Biopsy Verses Marrow Aspirates for Iron Scoring
In low numbers of human cases, iron assessment can be discrepant between the
marrow core biopsy and aspirate smears.[19] In some cases, iron may be
detectable on bone marrow core biopsy when none is detected on aspirate
smears.[19] This may be partially explained because at least seven marrow
particles must be present on aspirate smears to establish absolute iron
deficiency by the Gale method.[7, 19] Acquiring this number of particles may be a
challenge when only a small sample volume of bone marrow is collected. Also,
aspirates tend to have irregular distribution of iron which can further complicate
iron assessment.[6] Iron assessment by core biopsies may also be erroneous at
times. Iron staining by Prussian blue is recommended on plastic-embedded
samples.[6] Paraffin-embedded core biopsies can be used, but when combined
with decalcification, some iron can be lost.[19]
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CHAPTER THREE
PILOT AND UTILITY STUDY
Objectives
1. Evaluate the effect of different staining sequences on the iron scoring
systems.
2. Evaluate interobserver agreements of Gale score in healthy and ill
canines, with and without blood loss.
3. Investigate the correlation between Gale iron scores and CHr in healthy
and those ill canines with and without blood loss.
4. Provide descriptive statistics for iron Gale scores and CHr in healthy
research dogs and those ill dogs that are hematologically normal.
5. Determine how often that dogs with low marrow iron +/- low CHr have
evidence of absolute and subclinical iron deficiency based on clinical
findings and routine bloodwork.
Hypotheses
1. Destaining will decrease Gale iron scores by stripping stainable iron.[21]
2. The interobserver agreement will be fair to substantial with the Gale
method in both healthy canines and those ill canines with and without
blood loss.
3. The Gale score will not correlate to CHr in healthy and ill canines,
including categories of canines with and without blood loss because ill
dogs may commonly have iron sequestration due to hepcidin (e.g. anemia
of inflammatory disease) which may decrease the CHr but not decrease
the Gale score.
4. In healthy dogs and in clinically ill dogs that are hematologically normal,
the Gale iron score will be at least 1, and the CHr values will be similar to
those published reference intervals 24.5 to 28.6 pg (picograms).[2, 3]
5. Dogs with low Gale score and low CHr will commonly have other clinical
or laboratory evidence of absolute iron deficiency, while those with low
Gale score and normal CHr would uncommonly have other evidence of
absolute iron deficiency.
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CHAPTER FOUR
MATERIALS AND METHODS
Scoring Performance
Pilot Study
Bone marrow material remaining from aspirates collected as part of the clinical
evaluation of 20 canine patients at the University of Tennessee Veterinary
Medical Center (UTVMC) were selected prospectively by convenience sampling
(samples where nearby and easily attainable) from April 2017 to September
2018. As part of a standard clause on the UTVMC admissions form, clients of
these patients acknowledged by signature that any remaining diagnostic material
could be used for research. Eight canine patients were excluded because at
least one of the paired aspirate smears contained less than 7 marrow particles.
Seven particles is the minimum recommended number to determine lack of
stainable iron, as seen with absolute iron deficiency.[6]
The remaining 12 canines ranged in age from 3 to 11 years. These represented
a variety of breeds, including Golden Retriever (2), Beagle (2),
Labrador Retriever (2), West Highland White Terrier (1), mixed breed
(1), Staffordshire Terrier (1), Collie (1), Great Dane (1), and
Bichon Frisé (1). Clinical diagnoses included leukemia (5), immune-mediated
thrombocytopenia (2), vector-borne disease (2), precursor-directed immunemediated anemia (1), chronic kidney disease (1), and anemia of undetermined
origin (1).
Staining
All marrow aspirates were collected by UTVMC veterinarians in the Department
of Small Animal Clinical Sciences. Two smears were prepared from each of the
12 canine samples, generating a total of 24 smears. One smear from each
canine was stained directly with Prussian blue, while the other was first stained
with Wright stain, destained, and then restained with Prussian blue.
The initial Wright staining of the restained smears was performed via automatic
slide stainer (Aerospray Pro, ELITech Group Wescor, Puteaux, France). The
slides were then decolorized with an ethanol/hydrochloric acid (9:1) solution until
colorless, followed by a rinse with deionized water.
All 24 smears were then stained with Perls’ Prussian blue by a standard, staining
protocol performed at UTVMC Histology laboratory. This stain included steps of
1) fixation in methanol for 10 minutes, 2) incubation in a 1:1 solution of 10%
potassium ferrocyanide and 20% hydrochloric acid for 10 minutes, and 3)
counterstaining by flooding with 1% safranin for 10 seconds. Distilled water
7

rinses were used after each step. All smears were mounted with CoverSeal™-X
(Cancer Diagnostics, Durham, NC) and a coverslip applied. Positive controls for
each run included a histological sample of canine liver with increased amount of
large globular iron deposits and a canine blood film with moderate numbers of
siderocytes. These controls represented stainable storage iron for Gale scoring
and intracellular small iron granules for sideroblast scoring, respectively.
Scoring
The resulting 24 Prussian blue stained smears were randomized, and all labels
were concealed with a random number creating a double-blind study with three
independent observers. To assess intraobserver repeatability, after one round of
scoring, samples were re-randomized and relabeled for a second round of
scoring in which observers where blinded to previous scores. Observers
included two experienced boarded veterinary clinical pathologists and one
veterinary clinical pathology resident. Each observer used the same model of
microscope (Olympus BX41, Olympus Corporation, Tokyo, Japan). All marrow
aspirate smears were examined microscopically using the following protocols for
both Gale and Sideroblast scores. Each observer independently recorded both
Gale and Sideroblast scores for each sample without knowledge of results from
the other observers.
Gale
A published Gale scoring system from human literature was utilized (Image
1).[18] A short training session for all observers along with complied microscopic
images (Figure 2) corresponding to each Gale score (Table 1) was provided by
author DS. The entire smear was scanned using the 10x objective. Samples
with variable iron in different marrow particles were scored based on the highest
iron score, as they reflect the maximum amount of iron stores.
If iron was visible during this low power scan, Grades 3 to 6 were assigned, and
a high-power scan was not performed for that sample. A grade 2 was assigned if
there were small, sparsely distributed iron particles on low power, which were
confirmed as iron using a high-powered scan with the 50x or 100x objective. If
no iron was visible at low power, a high-powered scan evaluated at least 7
marrow particles for scant iron, distinguishing grades 0 and 1.
Sideroblast
The sideroblastic method was performed using the 100X oil immersion objective
in a well spread area, avoiding areas of excess macrophagic iron deposits. One
hundred nucleated erythrocyte precursors were counted, enumerating the
percentage that were sideroblasts. Any erythroid precursor was considered a
sideroblast (Figure 1) if it contained 1-5 small blue iron granules in the cytoplasm.
Iron granules occurring in a ring around the erythroid nucleus or diffusely, are
8

termed ring sideroblasts and were also included in the sideroblast
percentage.[10]
Statistical Analysis
All 24 marrow smears, including those directly stained and those destained
/restained, and repeated scores recorded by all three observers were included in
the analysis, yielding a total of 144 observations. The statistical software (SAS v
9.4, Cary, NC) was utilized for all analyses. A two-way analysis of variance
(ANOVA) was used to test the effect of destaining on the Gale and Sideroblast
scoring methods. Staining and observer were designated as treatments,
blocking on patient. The null hypotheses stated that all treatment means for
staining and observer were equal for both the Gale and Sideroblast scoring
methods. Cohen’s kappa was used to determine intraobserver agreement
between each observer’s first and second scorings of the Gale method for each
patient. Intraobserver agreement of the sideroblast method was evaluated by
Pearson correlation for continuous data. Fleiss’ kappa was used to determine
interobserver agreement of the three observers based on Gale method scorings.
Interobserver variability was analyzed via observer effect on sideroblast score by
two-way analysis of variance (ANOVA). The statistical software SPSS (IBM Corp.
Released 2021. IBM SPSS Statistics for Windows, Version 28.0. Armonk, NY:
IBM Corp) was used to perform an intraclass correlation coefficient (ICC) to
determine interobserver reliability. ICC has more power and is based on
continuous data and was added on as an additional way to audit interobserver
agreement.[22, 23]
Cohen’s Kappa (intraobserver variability) and Fleiss’ Kappa (interobserver
variability) values were interpreted with the Landis and Koch’s kappa agreement
scoring system. Interpretation of weighted kappa (Κω) values were as
follows: <0 no agreement, 0-0.20 slight agreement, 0.21-0.40 fair agreement,
0.41-0.60 moderate agreement, 0.61-0.80 substantial agreement, and 0.811 near perfect or perfect agreement.[24] The ICC was interpretated with
published, qualitative guidelines were as follows: <0.5 poor, 0.5 – 0.75 moderate,
0.75 – 0.9 good, and >0.9 excellent correlation.[25]
For intraobserver agreement, correlation (rho) was classified as positive or
negative. Interobserver variability was analyzed via observer effect on
sideroblast score by two-way analysis of variance (ANOVA). Correlation strength
was based on the rho values. A correlation (rho) of 0 to 0.3 was
considered weak correlation, 0.3 to 0.7 as moderate correlation, and above
0.7 as strong correlation.[26]

Larger Study Set
A larger and separate set of canine marrow aspirates and concurrent blood
samples included 139 clinically ill canines from Cornell University Hospital for
9

Animals (CUHA), 20 healthy research canines from UTVMC, and 12 canines
enrolled in a previous UTVMC nutritional iron deficiency study from 2005 [1].
Inclusion criteria for all sample groups were at least 7 marrow particles present
on the Prussian blue stained bone marrow smear and a CBC including
reticulocyte parameters obtained within 1 day of marrow sampling.
Additional inclusion criteria for the healthy research dogs were that they must be
at least one year of age and must be clinically healthy on physical exam, with no
evidence of external bleeding and no medications other than routine parasite
prevention within 10 days prior to sample collections. Samples from the healthy
research dogs were excluded if there was more than one CBC value or serum
iron biomarker outside of the reference intervals.
For dogs with experimentally induced iron deficiency, an additional inclusion
criterion was that the dog had to have been on an iron-restricted diet for at least
one month before marrow sampling.
After application of these inclusion and exclusion criteria, the final sample set
included samples from 118 clinically ill dogs from CUHA, 12 healthy research
dogs from UTVMC, and 4 canines from the nutritional iron deficiency study.
Canine marrow aspirate smears from the 118 patients at CUHA were
retrospectively identified from 2010 to 2014. These were collected and stained
with Prussian blue as part of the diagnostic evaluation of the patient, so required
no IACUC approval. Ages spanned 1 to 14 years. Breeds included mixed breed
(23), Golden Retriever (16), Labrador Retriever (15), Bernese Mountain dog (5),
Boxer (4), Dachshund (3), German Shepherd (3), Rottweiler (3), and 1-2 each of
various other breeds. There were a variety of clinical diagnoses, which included
neoplasia, inflammation, inflammation concurrent with neoplasia, immune
mediated disease, hemolytic anemia, external blood loss, and iron deficiency
anemia.
Blood and bone marrow samples were collected from sedated healthy research
dogs from a colony maintained by the UTCVM in 2020 and from research dogs
with experimental nutritional iron deficiency at UTCVM in 2005. All samples were
collected in accordance with an approved IACUC protocol (UT IACUC protocols
2791-1020 and 1385) Marrow was collected from a proximal humerus by IACUC
approved veterinarians in all cases. The healthy research colony included mostly
Beagles and 2 hounds, all aged 1 to 6 years. After application of inclusion and
exclusion criteria, the sample of healthy research dogs included 12 canines aged
1 to 4 years old, and all were Beagles. The research dogs with experimental iron
deficiency were young (ages 3-7 months) and mixed breed. After application of
inclusion and exclusion criteria, this group included 4 dogs.
10

All marrow samples from the CUHA patients were stained with Prussian blue at
the CUHA clinical pathology laboratory. Samples from the healthy UTVMC
research canines were shipped to CUHA for Prussian Blue staining in order to
mitigate interlaboratory variability. However, the samples from the dogs with
experimentally induced nutritional iron deficiency had already been stained by
Prussian blue through the UTVMC histology laboratory using the same protocol
as in the pilot study. The Cornell clinical pathology standard operating procedure
(SOP) for Prussian blue staining is adapted from published protocol, similar to
that used in the UTVMC histology laboratory for the pilot study.[27] Initially slides
were fixed for 10 minutes with methanol, incubated for 10 minutes with freshly
prepared and equal parts of 2% potassium ferrocyanide and 2% hydrochloric
acid, and finally counterstained by flooding with 1% safranin for 10 minutes.
Between each step and after the counter stain, slides were rinsed with distilled
water. After the final step slides were left to air dry and mounted with a standard
glue and covered with a coverslip.
For all dogs, a concurrent blood sample was placed in EDTA purple top tube (for
CBC with reticulocytes) and into a no-additive red top tube (for measurement of
serum iron, TIBC, and percent saturation of transferrin (%Sat). Concurrent CBC
data with reticulocyte parameters were analyzed for all dogs either via an ADVIA
2120 or 120 hematology analyzer (Siemens Healthcare Diagnostics
Inc.,Tarrytown, NY, USA). The CBCs for each group were performed using
different instruments, as follows: an ADVIA 2120 at CUHA for the CUHA patients,
an ADVIA 2120 at UTVCM for the healthy research dogs, and an ADVIA 120 at
UTVMC for the dogs with nutritional iron deficiency.
Serum iron, TIBC, and %Sat were measured on all UTCVM healthy research
canines, all dogs with experimental iron deficiency, and most CUHA patients
using the Cobas C501 chemistry analyzer (Roche Diagnostics, Indianapolis, IN,
USA) at the CUHA clinical pathology laboratory.
For the larger set, the statistical software SPSS (IBM Corp. Released 2021. IBM
SPSS Statistics for Windows, Version 28.0. Armonk, NY: IBM Corp) was used for
all data analysis. For intraclass correlation coefficient (ICC) analyses, published,
qualitative, interpretative guidelines were used: <0.5 poor, 0.5 – 0.75 moderate,
0.75 – 0.9 good, and >0.9 excellent correlation.[25] The previous pilot study
employed a Fleiss Kappa, which is based categorical ratings. Using the Fleiss’
Kappa, given that one rater observed a Gale score of 4 and the other a score of
5, these categorically do not agree, and some power could be lost even when the
weighted kappa (Κω) was used.[22, 23] ICC utilizes a continuous scale, and
accounts for the closeness of score of 4 and 5 between different observers.
However, Fleiss’ Kappa was more appropriate is some instances where
variability was interpreted with fewer categories i.e. observer agreement at lower
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iron Gale scores. Interpretation of Fleiss’ kappa was based on Κω values, which
were as follows: <0 no agreement, 0-0.20 slight agreement, 0.21-0.40 fair
agreement, 0.41-0.60 moderate agreement, 0.61-0.80 substantial agreement,
and 0.81-1 near perfect or perfect agreement.[24] Rationale for this statistical
analysis of samples in the lower half of the Gale score scale was to determine
agreement between observers at scores around the clinical decision limits for
detection of iron deficiency.
Interobserver Variability
ICC was used to determine interobserver reliability of all 134 samples.
Additionally, the ICC for all directly Prussian blue stained smears from the pilot
study and larger set smears was determined.
Assessment of Clinical Utility
All smears were assessed via Gale method by three observers. These included
two, experienced, board certified veterinary clinical pathologists and one
veterinary clinical pathology resident. All observers used the same model
microscope (Olympus BX41, Olympus Corporation, Tokyo, Japan). As defined
by the previous study, bone aspirates had at least 7 marrow particles that were
moderately sized, defined as at least occupying ¾ of a low power field (10x
objective) for particle standardization. Scoring was the same as our pilot study
using the Gale scoring method based on categorical values of 0 to 6 (Figure
2).[5] Based on results of the pilot study, sideroblast scoring was not performed
on the larger data set because of the significant observer effect.
Interobserver Variability at low iron scores
Fleiss’ kappa was also used to determine interobserver agreement of the three
observers only on those samples on the lower half of the Gale method scoring
scale, i.e. a Gale score of 0-2, with a total number of 25 samples. Rationale for
this statistical analysis of samples in the lower half of the Gale score scale was to
determine agreement by a stricter method between observers at scores around
the clinical decision limits for detection of iron deficiency.
Correlation of Gale Score and CHr
Spearman correlation on all 134 samples was used to investigate correlation
between the Gale scores and CHr. For each sample, the mean Gale iron score
for the three observers was utilized for comparison to the CHr. Interpretation of
the Spearman correlation coefficient was based on strength (1 to 0.9- perfect to
very high correlation, 0.9 to 0.7 high correlation, 0.5 to 0.7 moderate correlation,
0.5 to 0.3 low correlation, 0.3 to 0.0 negligible to no correlation) and direction
(negative verses positive).[28]
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Odds Ratio
Odd ratio was used to determine the odds of canines with a low CHr, defined as
equal to or less than the lower reference limit established in the UTVMC clinical
pathology laboratory (24.4 picograms), having a Gale score in the lower half of
the grading scale, i.e. 0-2.[18, 19, 29] The published canine reference range for
CHr of 24.5 to 28.6 pg was used.[2]
Healthy Canine Descriptive Statistics
Ideally, a sample size of at least 40 canines is needed to calculate reference
intervals based on recommendations from the American Society for Veterinary
Clinical Pathology (ASVCP), but reference interval estimates can be provided
with as few as 20 samples. [30] Since bone marrow sampling is a painful and
expensive procedure, 20 canines were targeted. However, since fewer than 20
samples could be included after applying the inclusion and exclusion criteria,
results from this group are presented only as descriptive statistics per ASVCP
guidelines. Descriptive statistics were used to determine the 12 healthy research
canine Gale scores and CHr values, including minimum, median, maximum,
mean, and standard deviation values.
Hematologically Normal, Clinically Ill Canines
The limitation of using healthy research dogs to define normal marrow iron stores
by the Gale method is that these dogs do not likely reflect the population of sick
canine patients that may have marrow sampled during clinical evaluation. In
order to address this limitation, an additional comparison group of dogs expected
to have adequate marrow iron stores was identified that included clinically ill dogs
without any evidence of iron-restricted erythropoiesis. Two proposed ways were
investigated for the definition of these hematological normal canines. The first
definition was more strict, requiring all CBC and iron biomarker values to be
within reference intervals. This included normal erythrocyte values (RBC, HGB,
MCV, MCH, MCHC, absolute reticulocyte count, CHr), leukocyte values (WBC
with absolute leukocyte counts (segmented neutrophils, band neutrophils,
lymphocytes, monocytes, eosinophils, and basophils), platelet values, and serum
biochemistry values (serum iron, TIBC, and percentage saturation). Additionally,
patients were excluded from this group if there was medical history of a condition
that could affect iron metabolism or erythropoiesis, including evidence of external
bleeding noted in the medical history that could lead to decreased marrow iron,
diagnosis of chronic kidney disease which could have affected erythropoiesis,
evidence of portosystemic shunting which could alter iron metabolism, and lastly
specific breeds such as Akita that have been documented to have a hereditary
microcytosis.[2, 3, 15, 31, 32] There were 13 CUHA canines that met these strict
criteria.
The less strict definition included a slightly larger set of 20 canines. Exclusion
criteria based on CBC and serum biochemistry in this sample were less strict,
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allowing inclusion if there were changes in WBC values or platelet values that
were unlikely to be associated with changes in iron metabolism, such as a stress
leukogram, mild thrombocytopenia, or thrombocytosis. Descriptive statistics
were performed for the CUHA as defined by both the strict and less strict
definition of hematologically normal but clinically ill canines. Values for both
proposed sets investigated Gale scores and CHr values based on minimum,
median, maximum, mean, standard deviation.
Differences in Gale scores
A Mann Whitney U test was performed on all of the mean Gale score from all
observers between 1) healthy research dogs verses all ill canines, 2)
hematologically normal ill dogs versus hematologically abnormal ill dogs, 3)
canines with and without clinically reported blood loss, and 4) dogs on an
experimentally iron-restricted diet versus healthy research dogs.
Difference in CHr
A Mann Whitney U test was performed on all of the mean Gale score from all
observers between 1) healthy research dogs verses all ill canines, 2)
hematologically normal ill dogs versus hematologically abnormal ill dogs, 3)
canines with and without clinically reported blood loss, and 4) dogs on an
experimentally iron-restricted diet versus healthy research dogs.
Concurrent Use of Gale and CHr
Utilization of the Gale score and concurrent CHr was used to identify dogs that
have either overt iron deficiency or those that could have some other underlying
pathology (e.g. covert blood loss) that might predispose to iron deficiency and
warrant clinical investigation for causes of blood loss. Determination of which
clinically-ill dogs had evidence of possible absolute iron deficiency was based on
two categories that include Gale scoring and CHr (Table 2). Within each
CHr/iron score category (1-2), the number of dogs that have evidence of each
type of iron-restricted erythropoiesis, using the (Table 3) were identified. These
categories included RBC parameters, iron values, and clinical information as
diagnostic criteria.
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CHAPTER FIVE
RESULTS AND DISCUSSION
Scoring Performance
Pilot Study
Staining
The Gale score was significantly higher for the directly stained smears when
compared to the destained smear from the same patient (p=0.004). The
differences were modest, averaging from 0.25 to 0.40 points higher in the nondestained smears depending on observer and patient.[5] The difference in
sideroblast scores between destained and directly stained smears was not
statistically significant (p=0.45).[5] Results from all control slides were
acceptable, with liver and blood samples showing large iron deposits and small
iron granules, respectively, in all staining runs.[5]
Scoring
There was not a statistically significant difference in iron scores between
observers by the Gale method (p=0.21) (Figure 3).[5] Fleiss’ kappa was utilized
for interobserver agreement, with directly stained and destained smears
analyzed separately since there was an effect of destaining on the Gale
method. For directly stained smears there was fair agreement, with an ordinal
measure Κω = 0.23 and a coefficient of concordance (CC) of 0.82. For destained
smears there was also fair agreement, with an ordinal measure Κω = 0.31 and a
CC of 0.81.[5] For directly stained smears there was fair agreement, with
an ordinal measure Κω = 0.23 and a coefficient of concordance (CC) of 0.82. For
destained smears there was also fair agreement, with an ordinal measure Κω =
0.31 and a CC of 0.81.[5] The ICC for interobserver reliability among the three
observers for unstained smears was 0.930 Cl (0.862, 0.967). This indicates
excellent reliability of all three observers.[25] The ICC for interobserver reliability
among the three observers for destained smears was 0.933 Cl (0.868, 0.969).
This indicates excellent reliability of all three observers.[25]

For the sideroblast method, the majority of sideroblasts had morphology typical
of that described in human marrow samples, with 1-5 fine iron granules. Very
rarely, possible ring sideroblasts were identified (Figure 1), but the maximum
number identified in a sample during the sideroblast count was two.[5] There was
a significant difference in scores between observers (p=0.002), with the scores
from one observer (average of about 9-11% sideroblasts per sample) being
slightly higher than the other two observers (average of about 4-5% sideroblasts
per sample) (Figure 4).[5]
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Results for Cohen’s weighted kappa for the duplicate scores from each observer
by the Gale method indicate substantial to perfect agreement (Table 4). Results
for non-destained and destained smears were analyzed separately since there
was an effect of destaining on the Gale method. Because the data for the
sideroblast method was continuous, intraobserver agreement for the duplicate
scores was evaluated using Pearson correlation and indicated moderate to
strong positive correlation (Table 5).

Larger Set
Interobserver Variability
The ICC for interobserver reliability among the three observers for all 134
samples was 0.935 Cl (0.914, 0.952). This indicates excellent correlation of all
three observers.[25] For the pilot study directly stained smears and larger set
smear the overall ICC was 0.938 Cl (0.919, 0.953).
Assessment of Clinical Utility
There is a statistically significant difference in iron scores between observers for
the 25 samples with lower Gale iron scores (score of ≤2 by at least one observer)
(p=0.001). Fleiss’ kappa was utilized for interobserver agreement. There was fair
agreement, with an ordinal measure Κω = 0.306, Cl (0.162 to 0.450).[24] Within
these 25 samples, all three observers gave the same grade in 8/25, while
observer(s) disagreed on the grade in 17/25, with the following details:
• Grade 0 by all three observers, n=6/25
• Grade 1 by all three observers, n=0/25
• Grade 2 by all three observers, n=2/25
• Grade 0 given by at least one observer and Grade 1-3 given by other
observer(s), n=10/25
• No observers gave a grade of 0, but observers gave varying scores
ranging from 1-3, n=7/25
In summary observers have the best agreement on Gale scores of 0 and the
worst agreement on Gale scores of 1 and 2. Additionally there was some
disagreement of Gale score of 3 when other observer scored a 0-2, however it
was not statistically significant when comparing all observers’ scores (p=0.014).
Correlation of Gale Score and CHr
When testing the correlation between the CHr to the Gale score (mean of the 3
observers) in the 134 samples, a spearman correlation coefficient was 0.132,
indicating a weak positive correlation that was not statistically significant
(p=0.134).
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Odds Ratio
The odds of a low CHr (equal or less than 24.4 pg) in a canine patient is 3.346
times higher in patients that have a low median Gale score (2 or less) compared
to those with a higher median Gale score (3 or higher) (OR) = 3.346, Cl (1.204 to
9.303).
Descriptive Statistics
Descriptive statistics of Gale scores are provided for the healthy research dogs
and the clinically-ill dogs that were defined as hematologically normal using a
more strict (group A) and a less strict (group B) definition (Table 6).
Differences in Gale scores
There was statistically significant difference in Gale iron scores (mean of all
observers) between healthy controls and ill canines (p=0.001) as tested by the
Mann Whitney U test. There was no statistically significant difference in the
mean Gale score of the strict definition (N=13) of hematologically normal verses
hematologically abnormal canines (p=0.145). However, Gale score in clinically-ill
dogs with the less strict definition (N=20) were significantly higher than clinicallyill and hematologically abnormal canines (p=0.019). There was not a statistically
significant difference in the mean Gale score based on the clinical presentation of
blood loss verses no blood loss (p=0.813). Dogs with experimentally induced
nutritional iron deficiency had a significantly lower Gale score compared to
healthy controls (p=0.003) as tested by the Mann Whitney U test.
Differences in CHr
There was not a statistically significant difference CHr of all observers in healthy
controls verses ill canines (p=0.719) as tested by the Mann Whitney U test. There
was no statistically significant difference in the CHr based the strict definition
(N=13) of hematologically normal verses hematologically abnormal canines
(p=0.214). There was not a statistically significant difference in the CHr based on
the less strict definition (N=20) of hematologically normal verses hematologically
abnormal canines (p=0.094). There was not a statistically significant difference in
the CHr based on the clinical presentation of blood loss verses no blood loss
(p=0.388). Dogs with experimentally induced nutritional iron deficiency had a
significantly lower CHr compared to healthy controls (p=0.004) as tested by the
Mann Whitney U test.
Concurrent Use of Gale and CHr
Based on criteria defined in Table 2 regarding CHr and marrow Gale score, there
were 9 canines in Group 1 (possible absolute iron deficiency, i.e. low CHr and low
Gale score) and 11 canines in Group 2 (possible subclinical absolute iron
deficiency, i.e. normal CHr and low Gale score). All laboratory and clinical
information from these patients were evaluated according to criteria in Table 3 to
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determine how many of these dogs had evidence of different causes of ironrestricted erythropoiesis.
GROUP 1 (Low CHr and low Gale score, n=9)
One dog in Group 1 met the criteria for absolute iron deficiency associated with
blood loss. This patient had microcytic and hypochromic anemia, low serum iron,
low %Sat, with evidence of external blood loss. Blood loss was secondary to a
small intestinal leiomyoma.
Three dogs in Group 1 met the criteria for absolute, nutritional iron deficiency.
These patients had microcytic and hypochromic anemia, low serum iron, low %Sat,
and had been on an experimental iron deficient diet for at least 77 days.
Two dogs in Group 1 had clinical evidence of predisposition to absolute iron
deficiency (chronic external blood loss and/or chronic NSAID administration but
with normal MCV, MCHC, serum iron, TIBC, and %Sat). One of these dogs had
recurrent episodes of epistaxis for two months, which was likely due to
hyperviscosity associated with a diagnosis of multiple myeloma. The other had
immune-mediated thrombocytopenia with about a one-week history of melena,
and had also been on the NSAID Metacam for osteoarthritis.
Two dogs in Group 1 were grouped in the iron sequestration category because
they had neoplasia or inflammation. One these dogs had multicentric large cell
lymphoma and was on thyroxine for hypothyroidism with a microcytic hypochromic
mildly regenerative mild anemia, low serum iron, and low %Sat. The other dog
had a pericardial mass, probable diaphragmatic hernia, normocytic normochromic
non-regenerative mild anemia, low serum iron, and low %Sat.
No dogs in Group 1 were classified in the functional iron deficiency category which
included dogs with hemolytic disease. One of the experimental nutritional deficient
dogs was not sub classified into the nutritional deficient categories as all-inclusive
categories were met except the anemia was normocytic hyperchromatic. This
patient’s hemolytic index was low therefore not likely a cause. Electrolytes and
lipemic index were not reported therefore the cause of the aberrant normocytic
hyperchromatic erythrocyte’s findings were unclear.
GROUP 2 (normal CHr and low Gale score, n=11)
In Group 2, subclinical absolute iron deficiency category there were 8 canines
with clinical or laboratory evidence of iron sequestration (inflammatory disease or
neoplasia). Diagnoses included multicentric large cell lymphoma (2),
hypereosinophilia of Rottweilers, severe stomatitis, mast cell tumor stage III,
chronic pancreatitis with PIMA, and splenic or liver histiocytic sarcoma.
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In Group 2, one dog was classified as functionally iron deficient. This patient was
diagnosed with probable immune mediated hemolytic anemia and had low
numbers of spherocytes and a weakly positive Coombs’ test.
No dogs fit the criteria for the absolute iron deficiency with blood loss, absolute
iron deficiency (functional), and predisposition to absolute iron deficiency. The
remaining dogs not classified included 2 canines with an open diagnosis
(possible PIMA) (1), and regenerative anemia of undetermined origin (1).
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CHAPTER SIX
CONCLUSIONS AND RECOMMENDATIONS

The pilot study evaluated the technical performance of two methods for scoring
iron stores in canine bone marrow aspirate samples stained by Prussian blue,
including assessments of interobserver agreement, intraobserver agreement,
and the effect of destaining Wright stained smears before staining with Prussian
blue. Our findings indicate that destaining prior to Prussian blue staining may
cause a modest decrease in iron scores by the Gale method. It has been
reported that the acids used in fixatives and decalcifiers in human histologic
marrow samples may remove some iron stores.[21] Therefore, it is possible that
the destaining procedure of acid and ethanol used in this study may have
stripped some iron from the samples. Alternatively, the difference noted in our
small sample set may reflect type I statistical error. In future studies, evaluation
of destaining methods that do not employ an acid, such as a microwave
technique, would be warranted.[33] Based on our results, performing Prussian
blue staining on unstained marrow slides is advisable.[5]
The Gale method of marrow iron scoring grades large deposits
of hemosiderin within macrophages on a scale of 0 (absent) to 6 (very heavy),
and correlates moderately well with chemical measures of marrow iron in
humans.[18] This method for iron scoring is very commonly used for evaluating
marrow iron stores in humans, but to the authors’ knowledge has not been
evaluated for use in canine marrow samples.[6, 7] Results from our study
indicate that Gale scoring has acceptable interobserver and intraobserver
agreement, and differences between observers were not statistically significant.
The sideroblast method of iron scoring evaluates for small iron granules
in nucleated erythroid precursors of any stage of maturation (sideroblasts).[7, 9]
The sideroblast score is considered a better indicator of cellular iron availability
that the Gale score.[7] However, the sideroblast score is more labor intensive
and difficult. In our experience, it was difficult to identify faint iron granules in
some cells and sometimes difficult to distinguish intracellular iron from
superimposed extracellular iron granules. There was a significant difference in
sideroblast scores between observers in our study, with one observer commonly
counting about twice as many sideroblasts compared to the other observers.[5]
This could be due to different visual sensitivities among the observers for
detecting sideroblasts. Also, observers likely counted different 100 erythroid
subsets, which may yield very different sideroblast percentages. This difference
between observers suggests that it is unlikely that sideroblast iron scores would
be highly reproducible by different pathologists, potentially limiting the clinical
utility of this measurement.[5]
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An additional notable finding was that the samples included in this study appear
to have much lower sideroblast scores than what is considered normal for human
marrow samples.[5] The dogs included in this study were clinically ill, so it is
possible that they may have had iron sequestration or functional iron deficiency
leading to decreased sideroblastic iron. Alternatively, there may be a species
difference in normal amounts of sideroblastic iron. Assessment of sideroblast iron
scores on additional canine samples would be useful, including samples from
healthy dogs.
Limitations of this pilot study include that the sample size was small and that
most samples fell in a limited range of Gale iron scores of 3-4. It would be useful
to evaluate interobserver and intraobserver agreement of more samples that
are at the most important clinical decision cutoff, which extrapolated from human
marrow samples would be between 0 and 1 for the Gale score. Of note in our
results, there was only one dog with Gale iron scores below 3, and scores for all
observers in the destained and non-destained smears from this patient ranged
from 0 to 2. Additionally, the method for defining a sideroblast was refined after
the first set of observations due to the difficulty in distinguishing superimposed
extracellular iron from sideroblast iron granules. This may have affected
intraobserver variability of the sideroblast score between the first and second
observations, although it should not have affected the interobserver variability for
each replicate.[5]
Based on these results, the Gale method for iron scoring performs adequately,
particularly when Prussian blue staining is performed on previously unstained
smears.[5] However, the sideroblast iron scoring method should be used with
caution due to significant interobserver variability.[5]
Interobserver variability of the larger set of 134 samples and in addition with the
directly Prussian blue stained smear from the pilot study indicated excellent
reliability among all three observers. Given the larger numbers of observations,
this larger set has more robust power. This enforces that the Gale method is
reproducible among observers. Additionally, reliability of the Gale method
among observers was acceptable at clinically relevant low iron scores (2 or less)
even though minor differences were seen between observers of Gale scores of 1
and 2 as seen from the Fleiss kappa. These differences would still classify the
patient with low iron. There were rare instances where some observers scored a
Gale score of 3 and others a Gale score of 0-2. This was not statistically
significant; however, could result in some patients being misclassified as iron
deficient and vice versa which could have a negative clinical impact. These
differences could be attributable to different visual sensitivities of the observers,
the locations of high-power scans, and length of time examining the smear.
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CHr correlates weakly with Gale score, and it is not an acceptable indicator of
marrow iron stores. This was an expected finding as different pathological
processes other than absolute iron deficiency can alter the CHr. Most notably in
iron sequestration with inflammatory processes, CHr is decreased and the Gale
score maybe normal. Alternatively, the odds of a canine patient given a low CHr
are approximately 3 times as likely to have a low Gale score. However, this is
merely a measure of association and is not predictive of every patient.
Therefore, CHr cannot be a surrogate for marrow iron stores and must be
interpretated considering clinical findings and other blood work parameters.
Descriptive statistics for healthy “control” canines suggest that Gale scores of 4
to 5 and CHr of 24.5 pg to 26 pg would likely be normal. Given that the Gale
range for healthy controls was 4 to 5 it may suggest that normal Gale scores for
canines maybe higher compared to the normal Gale scores in humans i.e. 1 to
3.[18, 19] The CHr range of 24.5 pg to 26 pg seems to correlate with previous
studies.[2, 3] The limitation of these values is that the number of observations is
low which limits the robustness of the data. Additionally, since all patients are
Beagles between the ages of 1- and 4-years old, variation is reduced. Therefore,
this sample set is likely not applicable to a population of various breed and ages
of canines. However, it is a starting place as a larger number of marrow
aspirates from patients may be difficult to sample in a controlled setting. Also as
mentioned obtaining marrow aspirates can be a very painful and expensive
procedure to perform. It would also be ideal to have core biopsies to compare to
the marrow aspirates. The core biopsies could provide and extra layer of
enforcement of the Gale scoring, as distribution iron could be more even.
However, to avoid repeated painful sampling a successful core was not taken on
most of the healthy canines.
The strict (Group A) and less strict (Group B) definition of hematologically normal
but clinically ill canines were similar with the less strict having slightly increased
mean and median Gale scoring. Both the strict and less strict subcategories
tended to mirror the mean and median Gale scores and CHr in the healthy
control groups. However, for both the strict and less strict hematological normal
but clinical ill canines the range of Gale scores were more variable than the
healthy controls. Results from the Mann Whitney U test showed that Gale scores
were higher with less strict (group B) canines compared to those hematologically
abnormal canines. Therefore, by using the less strict criteria which allowed for
changes in WBC values or platelet values, it is unlikely to be associated with
alterations in iron metabolism, the patient was more likely to have a Gale score
closer to the mean of the healthy control canines i.e. 4. Given the ranges of Gale
scores (Table 3.4.), Gale score of <2 in a clinically ill dog or <4 in a healthy dog
may warrant evaluation for a condition associated with iron restricted
erythropoiesis, such as external blood loss, nutritional deficiency, or conditions
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associated with iron sequestration or functional iron deficiency (e.g. inflammation,
neoplasia, or rapid erythropoiesis).
The fact that dogs with clinical evidence of blood loss could not be distinguished
from those dogs without clinical blood loss by the Gale score could be due to
differences in type of bleeding. For example, internal bleeding into body cavities
would allow for recycling of iron verses external to the body bleeding where iron
would be lost. Additionally, a limitation is that the evaluation for blood loss was
restricted to those with any amount of clinical evidence of bleeding documented
in the medical record. Therefore, no objective measurement of the amount of
external blood loss was available. Additionally, we cannot rule out that dogs
without clinically reported blood loss could have had subclinical external blood
loss.
Healthy control canines could be distinguished from the clinically ill canines by
the Gale score but not the CHr. Both the Gale score and CHr were significantly
lower in canines with experimental nutritional iron deficiency as compared to
healthy controls. Dogs with low CHr and low Gale score in our data set
commonly had evidence to support absolute iron deficiency. However, some
dogs in this category had additional evidence to support concurrent iron
sequestration or functional iron deficiency. None of the dogs with normal CHr
and low Gale score in our data set had evidence to support absolute iron
deficiency. Therefore, low Gale score may not be specific for absolute iron
deficiency, and it might be best to interpret it in conjunction with CHr. A limitation,
though, is that we cannot rule out that those dogs with normal CHr and low Gale
score may have early or subclinical iron deficiency.
In summary, the Gale score is a reliable method to semi-quantitate canine iron
marrow. Directly stained Prussian blue marrow aspirates are preferred.
Descriptive statistics for healthy Beagles include Gale scores of 4 to 5 and CHr of
24.5 pg to 26 pg. The Gale score and CHr should be interpreted with all
bloodwork and clinical data can ensure appropriate classification of iron restricted
erythropoiesis as subclinical iron deficiency or more than one restrictive iron
process may be present.
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Table 1 Gale scoring table
Score Summary
0
None
1

Very slight

2

Slight

3

Moderate

4

Moderately
heavy
Heavy
Very heavy

5
6

Description
No visible iron, even under high power (oil)
magnification
Any small intracellular iron particles only visible under
high power magnification (50x or 100x objective)
Small, sparsely distributed iron particles just visible
under low power magnification (10x objective)
Numerous small intracellular iron particles throughout
sample
Larger iron particles throughout sample with tendency
to aggregate in clumps
Dense, large clumps of iron throughout the sample
Very large deposits of iron obscuring cellular detail in
sample

Table 2 Absolute iron deficiency
Categorization of probability of dogs having absolute iron deficiency, based on
CHr and Gale score.

Group 1
Group 2

CHr
<24.4 pg
24.5-28.6 pg

Gale Score
< 2*
< 2*

Hypothetical causes
Probably has absolute iron deficiency
Suspicious for mild or incipient
absolute iron deficiency

*< 2 indicating a Gale score that was less than that of dogs that were clinically ill
but hematologically normal.
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Table 3 Iron deficiency categories
Absolute Iron
Deficiency,
blood loss
Absolute Iron
Deficiency,
Nutritional
Predisposition
to Absolute Iron
Deficiency
Iron
Sequestration
Functional Iron
Deficiency

None of the
Above

Diagnostic Criteria
Microcytic and hypochromic anemia, decreased serum iron,
decreased %Sat, AND external blood loss reported in the medical
record
Microcytic and hypochromic anemia, decreased serum iron,
decreased %Sat, AND experimental nutritional iron deficiency
(only those on the iron deficient diet for at least one month)
Clinical evidence of chronic external blood loss and/or chronic
NSAID administration but with normal MCV, MCHC, serum iron,
TIBC, and/or %Sat
Clinical or laboratory evidence of inflammatory disease or
neoplasia
Laboratory evidence of hemolytic disease, e.g. spherocytes, RBC
ghosts, agglutination or positive Coombs' test, more than rare
Heinz bodies or eccentrocytes, RBC parasites, hemoglobinuria
(positive heme w no sediment RBCs and normal serum CK), or
high indirect bilirubin without other evidence of cholestasis
Does not meet any of the above diagnostic criteria. Tabulate and
describe conditions included in this category.

Table 4 Gale variation
Intraobserver variation for duplicate Gale scores on Prussian blue stained
canine marrow aspirates, by Cohen’s weighted kappa. Non-destained slides
were stained initially with Prussian blue stain, while destained slides were
previously stained with Wright stain then decolorized before Prussian blue
staining. Agreement is based upon Landis and Koch.8
Observer
Stain
Kappa
Agreement
1
Non-destained
1.00
Perfect
1
Destained
0.78
Substantial
2
Non-destained
0.71
Substantial
2
Destained
1.00
Perfect
3
Non-destained
0.68
Substantial
3
Destained
0.74
Substantial
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Table 5 Sideroblast variation
Intraobserver variation for duplicate sideroblast scores on Prussian blue
stained canine marrow aspirates, by Pearson correlation. Non-destained slides
were stained initially with Prussian blue stain, while destained slides were
previously stained with Wright stain then decolorized before Prussian blue
staining. Degree of correlation is based upon Gaddis and Gaddis23
Observer Stain
P value
Rho value Degree of
Correlation
1
Non-destained
0.004
0.76
Strong positive
1
Destained
<0.0001
0.92
Strong positive
2
Non-destained
0.0003
0.87
Strong positive
2
Destained
0.0012
0.82
Strong positive
3
Non-destained
0.05
0.57
Moderate positive
3
Destained
0.05
0.57
Moderate positive

Table 6 Descriptive statistics
Healthy
Research

Sample size
Range of Gale
scores
Mean Gale score
Median Gale
score
Standard
Deviation of
mean

12
4-5

Clinically-ill but
hematologically
normal
(Group A)
13
2.67-5.0

Clinically-ill but
hematologically
normal
(Group B)
20
2.67-5.67

4.3
4.17

3.9
4.00

4.03
4.10

0.3

0.83

0.8
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Figure 1 Sideroblasts
Sideroblasts in canine marrow aspirate smears. A) A typical sideroblast
containing several very fine blue cytoplasmic iron granules, one of which is
indicated by the arrow. B) an apparent ring sideroblast, defined as an erythroid
precursor with greater than five cytoplasmic iron granules that encircle at least
two-thirds of the nucleus. C-D) an erythroid precursor with a single small granule
indicated by the arrow that is outside of the same focal plane as the surrounding
cells, so likely represents a superimposed extracellular iron granule. This cell
would not be included in the sideroblast count. 100x objective, Prussian blue
stain.
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Figure 2 Gale scoring images
Gale marrow scoring images. A-B) Score 0. C-D) Score 1. E-F) Score 2. G-H)
Score 3, example one. I-J) Score 3, example two. K-L) Score 4. M-N) Score 5.
Gale scores of 0-2 required a high power scan at the 100x objective. An
appropriate example of a grade 6 iron score was not available within the
available archived samples of canine marrow aspirates. The images in the left
column are low-power views using a 10x objective. The images in the right
column are high-power views using a 50x objective. Prussian blue stain.
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Figure 3 Gale variation
Interobserver variation in replicate Gale iron scores on marrow aspirate smears
from 12 dogs. Two smears were included for each dog, one that was previously
stained with Wright stain, then decolorized before Prussian blue staining (D,
destained) and one that was stained directly by Prussian blue (N, nondestained). Tall vertical lines were placed between patients for ease of viewing
separate patient results. Different colored markers indicate results for each of
three different observers.
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Figure 4 Sideroblast variation
Interobserver variation in replicate sideroblast iron scores on marrow aspirate
smears from 12 dogs. Two smears were included for each dog, one that was
previously stained with Wright stain, then decolorized before Prussian blue
staining (D, destained) and one that was stained directly by Prussian blue (N,
non-destained). Tall vertical lines were placed between patients for ease of
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viewing separate patient results. Different colored markers indicate results for
each of three different observers.
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